Neogenomics Inc
NEO· Nasdaq
NEONeogenomics Inc
Filed Feb 24, 2014 · 10-K · 55 days after period end · 0001193125-14-064714
| Metric | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|---|
| Net Income | $857.00K | -$114.00K | $152.00K | — |
| EPS Diluted | $0.02 | $0.00 | $0.00 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
ended Dec 31, 2013 · filed Feb 24, 2014 · 55 d after period end
